SIE 0.00% 6.8¢ scigen limited

sie - india deal postponed -- disappointing

  1. 2,371 Posts.
    lightbulb Created with Sketch. 80
    Despite a lengthier process than expected within the Indian Ministry of Health in the registration of SciGen's insulin in India, the process is now well under way and expected to conclude in the middle
    of this year with sales expected to commence in early FY 04 which is later than originally anticipated.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.